-
ASCEND Webinar — Inimmune and Two Bear Capital Case Study
August 09, 2021
Inimmune is a startup focused on creating novel immune modulating compounds to fight a host of immune diseases, and Two Bear Capital invested in them.
Read article -
ÌÇÐÄVlog Faculty Member Receives US Patent
August 09, 2021
As we live through the COVID-19 pandemic, increasingly there is pressure for laboratories and clinics to provide rapid, accurate diagnoses of human pathogens.
Read article -
August 09, 2021
Here are a few articles that our team is currently reading and we thought might interest our readers!
Read article -
August 09, 2021
Here are a few articles that our team is currently reading and we thought might interest our readers!
Read article -
Students2Startups – An Interview with Peter Webley
July 12, 2021
OIPC’s Amanda Byrd sat down with Peter Webley recently to discuss the Students2Startups program.
Read article -
Innovation in a Minute — Supporting the Next Generation of Innovators
July 12, 2021
In this month’s installment, Peter Webley shares his work with researchers, students and startup companies to foster innovation at ÌÇÐÄVlog and UAS.
Read article -
Innovation in a Minute — Supporting the Next Generation of Innovators
July 12, 2021
In this month’s installment, Peter Webley shares his work with researchers, students and startup companies to foster innovation at ÌÇÐÄVlog and UAS.
Read article -
ASCEND Webinar — Angel Investing — Ask the Expert!
July 12, 2021
New Mexico Angels is the only New Mexico-based group of individual, accredited angel investors focused on investing in early-stage companies in the Southwest
Read article -
ASCEND Webinar — Angel Investing — Ask the Expert!
July 12, 2021
New Mexico Angels is the only New Mexico-based group of individual, accredited angel investors focused on investing in early-stage companies in the Southwest
Read article -
Students2Startups – An Interview with Peter Webley
July 12, 2021
OIPC’s Amanda Byrd sat down with Peter Webley recently to discuss the Students2Startups program.
Read article